#77 — Amanda Feilding on the Clinical Applications Of Psychedelics

In this episode of Better Thinking, Nesh Nikolic speaks with Amanda Feilding about the transformative and therapeutic potential of psychedelic compounds and their clinical applications. Amanda Feilding has been called the ‘hidden hand’ behind the renaissance of psychedelic science, and her contribution to global drug policy reform has also been pivotal and widely acknowledged. Amanda was first introduced to LSD in the mid-1960s, at the height of the first wave of scientific research into psychedelics. Impressed by its capacity to initiate mystical states of consciousness and heighten creativity, she quickly recognised its transformative and therapeutic power. Inspired by her experiences, she began studying the mechanisms underlying the effects of psychedelic substances and dedicated herself to exploring ways of harnessing their potential to cure sickness and enhance wellbeing. In 1996, Amanda set up The Foundation to Further Consciousness, changing its name to the Beckley Foundation in 1998. She realised that the potential harms and benefits of cannabis and psychedelics could only be adequately assessed by developing a sound scientific understanding of their mechanisms of action. Through the Foundation, she set about using cutting-edge brain imaging technologies to examine the neurophysiological changes underlying altered states of consciousness. Her long-held aim is to further our understanding of consciousness and how changes in cerebral circulation and neuronal activity underlie the effects of various psychoactive substances, so that we can better harness their potential to improve the human condition. Episode link at https://neshnikolic.com/podcast/amanda-feildingSee omnystudio.com/listener for privacy information.